. Author manuscript; available in PMC: 2010 Jun 1.

Published in final edited form as: J Hypertens. 2010 May;28(5):1034–1043. doi: 10.1097/hjh.0b013e328336ade3

Table 1.

Characteristics of each group at 34 weeks of age

	WKY (n = 12)	SHR (n = 12)	SHR/ND (n = 12)	SHR/ND + cilnidipine (n = 12)	SHR/ND + amlodipine (n = 11)
BW (g)	451 ± 4	422 ± 6^*	722 ± 13^*	702 ± 10^*	698 ± 16^*
BG (mmol/l)	5.2 ± 0.2	5.4 ± 0.3	9.8 ± 1.0^*	9.1 ± 0.9^*	11.5 ± 0.8^*
PTG (mg/dl)	87 ± 5	78 ± 9	341 ± 41^*	174 ± 20^*,^#	350 ± 101^*
Pcre (mg/dl)	0.56 ± 0.02	0.55 ± 0.02	0.55 ± 0.02	0.55 ± 0.02	0.55 ± 0.02
PAngII (fmol/ml)	14 ± 2	15 ± 2	9 ± 3^*	6 ± 1^*	15 ± 3
TBARS (nmol/mg protein)	0.21 ± 0.02	0.28 ± 0.04	0.47 ± 0.03^*	0.27 ± 0.02^#	0.35 ± 0.08

Values are mean ± SE. BW, body weight; BG, postprandial blood glucose; Pcre, plasma creatinine; PAngII, plasma AngII; PTG, plasma triglyceride; SHR, spontaneously hypertensive rat; TBARS, thiobarbituric acid-reactive substances; WKY, Wistar–Kyoto rats.

P < 0.05 vs. WKY.

P < 0.05 vs. SHR/ND.